Atlas Trials

InSightec

84 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch InSightec

RecordFirmDate
Unilateral and Staged Bilateral Pallidothalamic Tractotomy Using Exablate MRgFUS in Advanced Parkinson's Disease. (NCT07764874)InSightec2026-09-01
EMBRACE Tremor BiFUS (NCT06974916)InSightec2025-04-22
Safety and Effectiveness of Blood-Brain Barrier Disruption (BBBD) in Subjects With Suspected Infiltrating Glioma (NCT04667715)InSightec2024-10-23
A Prospective, Randomized, Controlled Trial to Test Safety and Effectiveness of Unilateral Exablate MR-guided Focused Ultrasound Subthalamotomy in Patients With Early-Stage Parkinson's Disease (NCT06584383)InSightec2024-08-01
A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications (NCT05539196)InSightec2023-01-23
Blood Brain Barrier (BBB) Disruption Using Exablate Focused Ultrasound With Doxorubicin for Treatment of Pediatric DIPG (NCT05615623)InSightec2023-01-04
Blood Brain Barrier (BBB) Disruption Using Exablate Focused Ultrasound With Doxorubicin for Treatment of Pediatric Diffuse Intrinsic Pontine Gliomas (DIPG) (NCT05630209)InSightec2023-01-04
Echo-Focusing in Patients With Treatment-Resistant Neurologic and Psychiatric Indications (EF001) (NCT05089786)InSightec2022-12-31
MR-guided Focused Ultrasound Plus GCase (NCT05565443)InSightec2022-11-30
Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets (NCT05317858)InSightec2022-08-12
Blood-Brain Barrier Disruption (BBBD) for Liquid Biopsy in Subjects With GlioBlastoma Brain Tumors (NCT05383872)InSightec2022-08-08
A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Thalamotomy for the Treatment of Medication-Refractory Tremor Dominant Idiopathic Parkinson's Disease (NCT04991831)InSightec2022-04-28
Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption in GBM Patients (NCT04998864)InSightec2021-08-25
Evaluation of the Safety and Effectiveness of Bilateral Exablate Ablation of the Pallidothalamic Tract (PTT) for the Treatment of the Motor Complications of Parkinson's Disease (PD) (NCT04728295)InSightec2021-05-14
Exablate Blood-Brain Barrier Disruption for the Treatment of rGBM in Subjects Undergoing Carboplatin Monotherapy (NCT04417088)InSightec2020-11-06
Exablate Blood-Brain Barrier Disruption With Carboplatin for the Treatment of rGBM (NCT04440358)InSightec2020-10-13
Study of MRgFUS Exablate Treatment Following the Neuropathic Pain (NCT04649554)InSightec2020-10-08
Blood-Brain-Barrier Disruption With Cerezyme in Patient's With Parkinson's Disease (NCT04370665)InSightec2020-07-16
Bilateral Treatment of Medication Refractory Essential Tremor (NCT04112381)InSightec2020-06-30
Continued Access of Focal MR-Guided Focused Ultrasound for Localized Intermediate Risk Prostate Lesions (NCT03998657)InSightec2019-12-19
Exablate for LIFU Neuromodulation in Patients With Opioid Use Disorder (OUD) and/or Other Substance Use Disorders (SUDs) (NCT04197921)InSightec2019-11-27
Blood Brain Barrier Disruption (BBBD) Using MRgFUS in the Treatment of Her2-positive Breast Cancer Brain Metastases (NCT03714243)InSightec2019-09-18
A Feasibility Study on the Safety and Preliminary Efficacy of Bilateral Subthalamotomy Using MRgFUS for Treatment of PD (NCT03964272)InSightec2019-06-18
A Clinical Trial for the Safety and Effect of MRGuided FUS Subthalamotomy for Medication Refractory Parkinson's Disease (NCT04744493)InSightec2019-05-31
Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption (NCT03551249)InSightec2019-03-26
Staged Bilateral Exablate Treatment of Medication Refractory Essential Tremor (NCT03465761)InSightec2019-01-03
ExAblate Blood-Brain Barrier Opening for Treatment of Alzheimer's Disease (NCT03739905)InSightec2018-12-06
A Study to Evaluate Temporary Blood Brain Barrier Disruption in Patients With Parkinson's Disease Dementia (NCT03608553)InSightec2018-11-26
Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption for Treatment of Glioma (NCT03616860)InSightec2018-10-16
ExAblate Blood-Brain Barrier Disruption for Glioblastoma in Patients Undergoing Standard Chemotherapy (NCT03712293)InSightec2018-08-28
Blood-Brain Barrier Opening Using MR-Guided Focused Ultrasound in Patients With Amyotrophic Lateral Sclerosis (NCT03321487)InSightec2018-04-13
A Study to Evaluate the Safety and Efficacy of ExAblate Subthalomotomy for the Treatment of Parkinson's Disease Motor Features (NCT03454425)InSightec2018-02-27
ExAblate Pallidotomy for Medically-Refractory Dyskinesia Symptoms or Motor Fluctuations of Advanced Parkinson's Disease (NCT03319485)InSightec2018-02-09
Feasibility Study of ExAblate Thalamotomy for Treatment of Chronic Trigeminal Neuropathic Pain (NCT03309813)InSightec2017-12-01

Track InSightec automatically

Every clearance here is in the API, with alerts when new ones post.